CAS 3146-66-5
:5-butil-5-(2-propen-1-il)-2,4,6(1H,3H,5H)-pirimidinetriona
- 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-butyl-5-(2-propen-1-yl)-
- 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-butyl-5-(2-propenyl)-
- 5-Allyl-5-n-butylbarbituric acid
- 5-Butyl-5-(2-propen-1-yl)-2,4,6(1H,3H,5H)-pyrimidinetrione
- 5-Butyl-5-allylbarbituric acid
- 5-butyl-5-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione
- Allylbutylbarbituric acid
- Barbituric acid, 5-allyl-5-butyl-
- Idobutal
- NSC 27524
- n-Butylallylbarbitone
- n-Butylallylbarbituric acid
- Ver más sinónimos
- Precio más bajo
- Precio más alto
- Pureza más baja
- Pureza más alta
- Entrega estimada más rápida
Idobutal
CAS:Producto controladoApplications Idobutal is used in the biotransformation of drugs, quantitative structure-activity relations, substance for the determination of barbiturates in the urine by using enzyme immunoassay and radio immunoassay, estimation of the solubility of drug like-organic compounds-case study in barbiturates.
References Tong, G. L., et al.: J. Pharm. Sci., 65, 1651 (1976); Law, B., et al.: J. Forensic Sci. Soc., 21, 55 (1981); Louis, B., et al.: Chem. Biol. Drug Des., 74, 190 (2009)Fórmula:C11H16N2O3Forma y color:NeatPeso molecular:224.26Idobutal
CAS:Producto controladoIdobutal is a potent anticancer drug that is an analog of dabigatran, a human and Chinese protein. It has been shown to inhibit the activity of kinases in cancer cells, leading to apoptosis or programmed cell death. Idobutal is an inhibitor of tumor growth and has been found to be effective against several types of cancer, including breast, lung, and colon cancer. This drug is excreted in urine and has been shown to have minimal side effects. Its ability to target specific proteins and kinases makes it a promising candidate for the treatment of various types of cancer.
Fórmula:C11H16N2O3Pureza:Min. 95%Peso molecular:224.26 g/mol

